Lou F. M. H. de Leij

Author

Also Known As

L F de Leij, Lou F M H de Leij, Lou F M. H de Leij, Lou F. M. H. De Leij, Lou F. M. H. de Leij, Lou F.M.H de Leij, Lou F.M.H. De Leij, Lou F.M.H. de Leij, Lou F. M. H. de Leij, Lou F.M.H. De Leij

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Groningen University Medical Center Groningen Dialyse Centrum Groningen Target (United States)

About

Lou F. M. H. de Leij is an author at University of Groningen specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.1K
2	Engineering	1	1	43
3	Health Sciences	1	1	61
4	Natural Sciences	1	1	20
5	Public Health	1	1	124

Lou F. M. H. de Leij

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer Klaas Kok, Jan Osinga, B. Carritt, Nature ChromatinGenome InstabilityMedicineGeneticsChromosomal Region 3P21	1987	394
Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle Angelique L. Veenstra van Nieuwenhoven, Annechien Bouman, H. Moes, Fertility and Sterility Maternal ImmunizationInfertilityReproductive HealthImmunologyGynecology	2002	124
BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the Proteasome Bart‐Jan Kroesen, S. Jacobs, Benjamin J. Pettus, Journal of Biological Chemistry	2003	112
Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFR Edwin Bremer, Douwe F. Samplonius, Linda van Genne, Journal of Biological Chemistry Signal TransductionSimultaneous InhibitionTherapeutic Apoptosis InductionSignaling PathwayReceptor Tyrosine Kinase	2005	97
Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7 Edwin Bremer, Douwe F. Samplonius, Matthias Peipp, Cancer Research	2005	88
Fas Receptor Clustering and Involvement of the Death Receptor Pathway in Rituximab-Mediated Apoptosis with Concomitant Sensitization of Lymphoma B Cells to Fas-Induced Apoptosis Alja J. Stel, Bram ten Cate, S. Jacobs, The Journal of Immunology	2007	83
Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study Astrid J. Schraa, Robbert J. Kok, Henk E. Moorlag, International Journal of Cancer Rgdpep-humab ConjugateEndothelial CellsImmunologyCell DeathRgdpep-humab Conjugate Bound	2002	73
Signaling through CD5 Activates a Pathway Involving Phosphatidylinositol 3-Kinase, Vav, and Rac1 in Human Mature T Lymphocytes Sonja I. Gringhuis, Lou F. M. H. de Leij, Paul J. Coffer, Molecular and Cellular Biology	1998	73
Donor Brain Death Aggravates Chronic Rejection after Lung Transplantation in Rats Noëlle Zweers, Arjen H. Petersen, Joost A.B. van der Hoeven, Transplantation	2004	72
The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy. Pamela M.J. McLaughlin, Martin C. Harmsen, Wim H.A. Dokter, PubMed Egp-2 ExpressionImmunologyImmunotherapyCancer BiologyTumor Biology	2001	67

Page 1